1. Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR.
Underestimation of liver-related mortality in the United
States. Gastroenterology. 2013; 145(2):375-382.e1-2.
doi:10.1053/j.gastro.2013.04.005.
2. Scaglione S, Kliethermes S, Cao G, et al. The Epidemiology of
Cirrhosis in the United States: A Population-based Study. J
Clin Gastroenterol. 2015; 49(8):690-696.
doi:10.1097/MCG.0000000000000208.
3. Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology
of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol
Hepatol. 2020; 18(12):2650-2666.
doi:10.1016/j.cgh.2019.07.060.
4. Newman JM, Schiltz NK, Mudd CD, Szubski CR, Klika AK,
Barsoum WK. Impact of Cirrhosis on Resource Use and
Inpatient Complications in Patients Undergoing Total Knee
and Hip Arthroplasty. J Arthroplasty. 2016; 31(11):2395-
2401. doi:10.1016/j.arth.2016.04.011.
5. Onochie E, Kayani B, Dawson-Bowling S, Millington S, Achan
P, Hanna S. Total hip arthroplasty in patients with chronic
liver disease: A systematic review. SICOT-J. 2019; 5:40.
doi:10.1051/sicotj/2019037.
6. Nicoll A. Surgical risk in patients with cirrhosis. J
Gastroenterol Hepatol. 2012; 27(10):1569-1575.
doi:10.1111/j.1440-1746.2012.07205.x.
7. Berstock JR, Beswick AD, Lenguerrand E, Whitehouse MR,
Blom AW. Mortality after total hip replacement surgery. Bone
Jt Res. 2014; 3(6):175-182. doi:10.1302/2046-
3758.36.2000239.
8. Hunt LP, Ben-Shlomo Y, Clark EM, et al. 90-day mortality after
409,096 total hip replacements for osteoarthritis, from the
National Joint Registry for England and Wales: a retrospective
analysis. Lancet Lond Engl. 2013; 382(9898):1097-1104.
doi:10.1016/S0140-6736(13)61749-3.
9. Cram P, Lu X, Kaboli PJ, et al. Clinical characteristics and
outcomes of Medicare patients undergoing total hip
arthroplasty, 1991-2008. JAMA. 2011; 305(15):1560-1567.
doi:10.1001/jama.2011.478.
10. Hillerson D, Ogunbayo GO, Salih M, et al. Outcomes and
Characteristics of Myocardial Infarction in Patients with
Cirrhosis. J Invasive Cardiol. 2019; 31(7):E162-E169.
11. An J, Shim JH, Kim SO, et al. Prevalence and Prediction of
Coronary Artery Disease in Patients with Liver Cirrhosis.
Circulation. 2014; 130(16):1353-1362.
doi:10.1161/CIRCULATIONAHA.114.009278.
12. Westerkamp AC, Lisman T, Porte RJ. How to minimize blood
loss during liver surgery in patients with cirrhosis. HPB
(Oxford). 2009; 11(6):453-458. doi:10.1111/j.1477-
2574.2009.00078.x.
13. Liu P, Hum J, Jou J, Scanlan RM, Shatzel J. Transfusion
strategies in patients with cirrhosis. Eur J Haematol. 2020;
104(1):15-25. doi:10.1111/ejh.13342.
14. Senzolo M, Sartori MT, Lisman T. Should we give
thromboprophylaxis to patients with liver cirrhosis and
coagulopathy? HPB (Oxford). 2009; 11(6):459-464.
doi:10.1111/j.1477-2574.2009.00079.x.
15. Anand AC. Nutrition and Muscle in Cirrhosis. J Clin Exp
Hepatol. 2017; 7(4):340-357. doi:10.1016/j.jceh.2017.11.001.
16. Jiang SL, Schairer WW, Bozic KJ. Increased rates of
periprosthetic joint infection in patients with cirrhosis
undergoing total joint arthroplasty. Clin Orthop.
2014; 472(8):2483-2491. doi:10.1007/s11999-014-3593-y.
17. McLawhorn AS, Buller LT. Bundled Payments in Total Joint
Replacement: Keeping Our Care Affordable and High in
Quality. Curr Rev Musculoskelet Med. 2017; 10(3):370-377.
doi:10.1007/s12178-017-9423-6.